Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Department of Physics, University of Washington, Seattle, WA, USA.
Nucleic Acids Res. 2022 Nov 11;50(20):11876-11894. doi: 10.1093/nar/gkac1026.
The conserved RNA helicase UPF1 coordinates nonsense-mediated mRNA decay (NMD) by engaging with mRNAs, RNA decay machinery and the terminating ribosome. UPF1 ATPase activity is implicated in mRNA target discrimination and completion of decay, but the mechanisms through which UPF1 enzymatic activities such as helicase, translocase, RNP remodeling, and ATPase-stimulated dissociation influence NMD remain poorly defined. Using high-throughput biochemical assays to quantify UPF1 enzymatic activities, we show that UPF1 is only moderately processive (<200 nt) in physiological contexts and undergoes ATPase-stimulated dissociation from RNA. We combine an in silico screen with these assays to identify and characterize known and novel UPF1 mutants with altered helicase, ATPase, and RNA binding properties. We find that UPF1 mutants with substantially impaired processivity (E797R, G619K/A546H), faster (G619K) or slower (K547P, E797R, G619K/A546H) unwinding rates, and/or reduced mechanochemical coupling (i.e. the ability to harness ATP hydrolysis for work; K547P, R549S, G619K, G619K/A546H) can still support efficient NMD of well-characterized targets in human cells. These data are consistent with a central role for UPF1 ATPase activity in driving cycles of RNA binding and dissociation to ensure accurate NMD target selection.
UPF1 是一种保守的 RNA 解旋酶,通过与 mRNA、RNA 降解机制和终止核糖体结合,协调无意义介导的 mRNA 降解(NMD)。UPF1 ATP 酶活性与 mRNA 靶标识别和降解完成有关,但 UPF1 酶活性(如解旋酶、移位酶、RNP 重塑和 ATP 酶刺激的解离)影响 NMD 的机制仍未完全定义。我们使用高通量生化测定来定量 UPF1 酶活性,结果表明,在生理环境中,UPF1 的活性仅具有中等的延伸性(<200nt),并且会在 ATP 酶刺激下从 RNA 上解离。我们将计算机筛选与这些测定相结合,以鉴定和表征具有改变的解旋酶、ATP 酶和 RNA 结合特性的已知和新型 UPF1 突变体。我们发现,具有明显降低的延伸性(E797R、G619K/A546H)、更快(G619K)或更慢(K547P、E797R、G619K/A546H)解旋速度以及/或降低的机械化学耦联(即利用 ATP 水解做功的能力;K547P、R549S、G619K、G619K/A546H)的 UPF1 突变体仍能支持人类细胞中经过充分表征的靶标进行有效的 NMD。这些数据与 UPF1 ATP 酶活性在驱动 RNA 结合和解离循环以确保准确的 NMD 靶标选择中的核心作用一致。